| Kirsten Greineder Engel, MD | |
|
55 Fruit St, Boston, MA 02114-2696 | |
| (617) 726-2000 | |
| Not Available |
| Full Name | Kirsten Greineder Engel |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 26 Years |
| Location | 55 Fruit St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033191770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036.119194 (Illinois) | Secondary |
| 207PH0002X | Emergency Medicine - Hospice And Palliative Medicine | 281727 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike.
The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $783,906 grant to Suzanne Mitchell, MD, a family physician at Boston Medical Center, to study health outcomes of minority women with type 2 diabetes who participate in group medical visits to help them manage their diabetes.
› Verified 3 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike.
The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $783,906 grant to Suzanne Mitchell, MD, a family physician at Boston Medical Center, to study health outcomes of minority women with type 2 diabetes who participate in group medical visits to help them manage their diabetes.
› Verified 3 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike.
The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $783,906 grant to Suzanne Mitchell, MD, a family physician at Boston Medical Center, to study health outcomes of minority women with type 2 diabetes who participate in group medical visits to help them manage their diabetes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kirsten Greineder Engel, MD 55 Fruit St, Boston, MA 02114-2696 Ph: () - | Kirsten Greineder Engel, MD 55 Fruit St, Boston, MA 02114-2696 Ph: (617) 726-2000 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike.
The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $783,906 grant to Suzanne Mitchell, MD, a family physician at Boston Medical Center, to study health outcomes of minority women with type 2 diabetes who participate in group medical visits to help them manage their diabetes.
› Verified 3 days ago
Yeu-shin Cindy Chang, M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Bwh Dept. Of Emergency Medicine, Boston, MA 02115 Phone: 617-732-8070 | |
Lorenzo Albala, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Dr. Jacob Ari Hurwitz, MD MPH Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Christopher Lites, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Aneesh T Narang, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Boston Medical Ctr Pl, Dowling 1 South, Boston, MA 02118 Phone: 617-414-5481 Fax: 617-414-7759 | |
Dr. Justin Thomas Pitman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Neville House - 236a, Boston, MA 02115 Phone: 617-732-8070 | |
Dr. Nadine Youssef, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Box 311 / Department Of Emergency Medicine, Boston, MA 02111 Phone: 617-636-4723 |